LifeArc announces £5 million drug repurposing programme for motor neuron disease
Filter by:
  • All
  • News Releases
  • Articles & blogs
  • Ventures Funding
    • News Releases 14 June 2019

    LifeArc invests £1.5 million in Ducentis BioTherapeutics

    LifeArc’s Seed Fund has invested £1.5 million in Ducentis BioTherapeutics to develop novel drug therapies for inflammatory and autoimmune disease